The November edition of ‘BioTuesday’, organised by OBN, will focus on rare disease research and development (R&D) in the UK and features a dynamic list of speakers, including On The Pulse director, Laurence Woollard.
OBN’s BioTuesday events bring together life science professionals to engage in the latest news and advances in specific therapy areas, followed by a series of R&D showcase presentations and networking.
Laurence will be sharing an update on therapeutic progress in haemophilia as part of a packed agenda with representatives from LifeArc, Healx, Ambrose Healthcare, Blackfin Bio and Immutrin. All aspects of the end-to-end pathway of drug development in rare diseases will be debated and discussed.
The event is taking place on Tuesday 12th November 2024, 18:00-21:30 GMT at Ipsen’s UK headquarters in Paddington, London.
For more information about the event programme, please visit OBN’s webpage here.
Acknowledgements
A special mention to Amy Hunter at Genetic Alliance UK for facilitating the opportunity and Jane O’Driscoll at OBN for coordinating Laurence’s involvement.
Get in touch
For all work-related enquiries, please email Laurence at: [email protected].